Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control.
about
Optimizing antibiotic therapy in the intensive care unit setting.Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry.Decreased antimicrobial resistance after changes in antibiotic use.Potential role of pharmacokinetics, pharmacodynamics, and computerized databases in controlling bacterial resistance.Strategies for study of the role of cycling on antimicrobial use and resistance.Emerging antimicrobial resistance in the surgical compromised host.Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.Systematic review of the literature and evidence-based recommendations for antibiotic prophylaxis in trauma: results from an Italian consensus of experts.The role of methicillin-resistant Staphylococcus aureus in orthopaedic implant surgery.Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infectionsColonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?Prophylactic use of vancomycin in adult cardiology and cardiac surgery.Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections.Methicillin-resistant Staphylococcus aureus: an overview for manual therapists().Management of severe bacterial infections.Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.Antimicrobial therapy of Staphylococcus aureus bloodstream infection.Emerging cephalosporins.Advances in MRSA drug discovery: where are we and where do we need to be?Fight evolution with evolution: plasmid-dependent phages with a wide host range prevent the spread of antibiotic resistance.Antimicrobial resistance development following surgical site infections.The role of perioperative care in reducing rates of methicillin resistant Staphylococcus aureus.Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.Emergence of vancomycin-resistant enterococci in San Francisco Bay area hospitals during 1994 to 1998.Prior antibacterial drug exposure in dogs with meticillin-resistant Staphylococcus pseudintermedius (MRSP) pyoderma.Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.The best hospital practices for controlling methicillin-resistant Staphylococcus aureus: on the cutting edge.Modeling methicillin-resistant Staphylococcus aureus in hospitals: transmission dynamics, antibiotic usage and its history.Are there regional variations in the diagnosis, surveillance, and control of methicillin-resistant Staphylococcus aureus?Modelling mechanical and chemical treatment of biofilms with two phenotypic resistance mechanisms.Novel anti-staphylococcal targets and compounds.Phenotypic detection of nosocomial mecA-positive coagulase-negative staphylococci from neonates.Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices.The MRSA Epidemic and/as Fluid Biopolitics
P2860
Q24796204-025664C9-FA03-4201-9E2A-93A3FF67EFF3Q27638972-06F86768-C810-4242-9F46-5339C0B39903Q33717173-17571D50-56AA-473C-A1F2-15DBD82A3AE4Q33827951-4E26FDCF-5A56-42D1-A09A-271A89F37AB0Q33827964-FBD6DE03-E0E8-48DD-A2D7-264BAE329998Q33840102-921ED6BF-2D57-4056-974B-F5EAE1F627CAQ34052619-0E2D17D0-453E-46F8-83CC-30A5BB14BDF3Q34550099-FA155871-75C9-46C9-96FE-B7B18748ECBFQ34590140-1B53FEB0-51A3-433E-AC88-58D616613D55Q35598469-8D79B198-C7D2-4DC7-80DD-8557804D6576Q35736907-AC0B2262-A66F-4C5D-A2C2-C1A02D05D237Q35750208-A40AD67E-249E-4B19-B8D3-532C6E789255Q35799727-F3F2642E-DB2F-4E31-A6CD-8612A7D67442Q35862069-8220311A-0755-4861-9AA8-F313E8FDAF13Q36233511-7B316D83-721E-4C67-AD91-03BFDB8830D3Q36409465-69D6C0C8-01E5-484A-94D0-7E3D3EBDC14AQ36968150-4BF075CB-DB67-4F8D-BC96-405FF8DA0E72Q36989896-4C369237-250C-48DA-A479-382A4389CAE8Q37112508-EA3179BE-A59A-45E0-8E5C-E2CA58CCD0CFQ37187865-4FC79304-9DC6-4380-B78B-D5E99FB3648DQ37720047-47ABF0C5-BBEA-445A-91ED-EE69BC05DBD6Q37977455-BBB95E3D-ABB1-4D5F-A313-879919F688CCQ38825167-AED73969-FE3D-441C-B925-58183A029DE0Q39686975-954EF9A2-5F31-423F-A20C-454A836EF3B3Q40779607-5B5B0593-A8AA-42BB-9081-5CDA682360AFQ40938813-797A0C03-23CD-4CD3-8241-FB174835D423Q42672133-F5FECEE5-6617-48F7-AC55-7E4D01D5452BQ42857859-88A21C5A-159B-4E51-BCC4-08D40FBB4BDDQ44464874-CCF8FF6C-6FFD-433F-A944-1BDEE25C2C87Q51010917-3919392B-EF12-4A01-AFFF-1E37F9CDBF4BQ53852773-84A3B441-6D2E-4486-930D-B293F3B532EFQ54076878-4A9AA269-B623-449C-A2AF-94B4D25CA3D7Q54083827-EAA7520D-FAEF-41E5-8BDC-95650DE76C03Q57984679-70103145-063E-4B74-B554-A8396BD037A8
P2860
Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Genesis of methicillin-resista ...... agement and infection control.
@ast
Genesis of methicillin-resista ...... agement and infection control.
@en
Genesis of methicillin-resista ...... agement and infection control.
@nl
type
label
Genesis of methicillin-resista ...... agement and infection control.
@ast
Genesis of methicillin-resista ...... agement and infection control.
@en
Genesis of methicillin-resista ...... agement and infection control.
@nl
prefLabel
Genesis of methicillin-resista ...... agement and infection control.
@ast
Genesis of methicillin-resista ...... agement and infection control.
@en
Genesis of methicillin-resista ...... agement and infection control.
@nl
P2093
P356
P1476
Genesis of methicillin-resista ...... agement and infection control.
@en
P2093
Birmingham MC
Paladino JA
Schentag JJ
P304
P356
10.1086/520287
P407
P577
1998-05-01T00:00:00Z